Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
QUESTION: In patients with acute ischaemic stroke, is thrombolytic treatment safe and effective for reducing mortality and intracranial haemorrhage, and for improving functional outcome?
Studies were identified by searching the Cochrane Specialised Register of Controlled Trials and EMBASE/Excerpta Medica, hand searching neurological and stroke journals, writing to 321 pharmaceutical companies for information, and reviewing meeting abstracts and conference proceedings.
Studies were selected if they were randomised controlled trials that compared thrombolytic drugs with placebo or control treatment in patients with definite acute ischaemic stroke. Trials were excluded if the treatment or control group received another active treatment not factored into the randomisation.
Data were extracted on patients, drug dose, administration route, duration of treatment, stroke type, results of computed tomography, and duration of follow up. Outcomes were all-cause mortality 7 to 10 days after treatment, symptomatic or fatal …
For correspondence: Professor J M Wardlaw, Western General Hospital, Edinburgh, Scotland, UK..
Source of funding: no external funding.